from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3121/cyp141

LFCtreatmentdescriptionclass of inhibitor

0.009

Amikacinug/mL Amikacintranslation

-0.003

Cap5-10ug/mL Capreomycintranslation

-0.450

Rox10-50 ug/mL Roxithromycintranslation

0.311

SM2-5 ug/mL Streptomycintranslation

-1.569

Tet5-10 ug/mL Tetracyclinetranslation

1.076

Rif0.2-5ug/mL Rifampicintranscription

0.967

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.345

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.314

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.211

CPZ10-50 ug/mL Chlorpromazinerespiration

0.815

Clofazimine10-13 ug/mL Clofaziminerespiration

0.671

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.143

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.505

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.396

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.934

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.737

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.957

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.231

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.704

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.987

Nigericin50 uM Nigericinrespiration

-0.362

TRC10-150 ug/mL Triclosanrespiration

0.220

TRZ10-25 ug/mL Thioridazinerespiration

-1.107

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.365

menadione6-10 ug/mL Menadionerespiration

-0.266

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.309

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.567

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.302

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.324

NRP_1Non-replicating persistence stage 1dosRassociated

0.532

Amp0.2mg/mL AmpicillincellWall

0.720

Cephalexin20-100 ug/mL CephalexincellWall

0.190

Cerulenin0.32-5 ug/mL CerulenincellWall

0.803

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.159

EMB10-20 ug/mL EthambutolcellWall

-0.125

Eta12-40 ug/mL EthionamidecellWall

-0.113

INH0.2-0.4 ug/mL IsoniazidcellWall

0.230

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.159

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.642

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.244

BZA0.12 mg/mL BenzamidearomaticAmides

0.129

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.281

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.473

H2O24 mM hydrogen peroxideDNAdamaging

0.250

Levo10 ug/mL LevofloxacinDNAdamaging

0.377

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.269

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.197

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.168

UVUV-irradiationDNAdamaging

-1.499

ARP41-4 ug/mL Antitubercular compound ARP4?

0.293

Antimycin12.5-50 ug/mL Antimycin A?

-0.137

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.248

PA_110-50 ug/mL Antitubercular compound PA-1?

0.547

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.996

PA8240.2-2 ug/mL PA-824?

-0.117

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.803

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.013

Verapamil50 uM Verapamil?

-0.814

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.291

methoxatin10-20 ug/mL Methoxatin?